Description:
This
program discusses the incidence and implications of acute kidney injury (AKI),
including new biomarkers that can predict patient risk for AKI, which could
allow physicians to intervene and potentially avoid the morbidity and mortality
associated with the condition. Also discussed are heart failure biomarkers and
their advantages and limitations in heart failure patients being treated with
the new heart failure drug ENTRESTO.
Learning Objectives:
- Outline
the importance of early diagnosis of acute kidney injury.
- Detail
relevant biomarkers and a new diagnostic tool for predicting acute kidney
injury.
- Describe
strategies that can be used to enhance a laboratory's value in diagnosing acute
kidney injury.
- Name
biomarkers used in heart failure assessment, and the strengths and limitations
of each biomarker.
Author(s):
Robert A. Elverson, MMGT, BS MT(ASCP)
Launched: 2016